Biocon Biologics Inc. et al. v. Regeneron Pharmaceuticals, Inc. > Summary
Court Case Number IPR2024-00201
Filing Date Nov 20, 2023
Institution Decision Date Jan 16, 2024
Decision Date Jul 30, 2024
Court Patent Trial and Appeal Board
Status Terminated
Administrative JudgesJohn G. New
Judge Writing the Final DecisionJohn G. New
Claims Challenged in the Petition: 10, 11, 12, 17, 18, 19, 21, 25, 26, 27, 28, 33
Claims Instituted: 10, 11, 12, 17, 18, 19, 21, 25, 26, 27, 28, 33
Claims Invalidated: 10, 11, 12, 17, 18, 19, 21, 25, 26, 27, 28, 33
Petitioner
Patent Owner
Petitioner Attorneys
10Biocon Biologics Limited
Attorney Name: Edward Chaum
Vanderbilt University
Biocon Biologics Limited
Attorney Name: Thomas H. Ehrich
Rakoczy Molino Mazzochi Siwik
Biocon Biologics Limited
Attorney Name: Steven J. Birkos
Rakoczy Molino Mazzochi Siwik
Biocon Biologics Limited
Attorney Name: Eric R. Hunt
Rakoczy Molino Mazzochi Siwik
Biocon Biologics Limited
Attorney Name: Neil B. McLaughlin
Rakoczy Molino Mazzochi Siwik
Biocon Biologics Limited
Attorney Name: Scott G. Bell
Rakoczy Molino Mazzochi Siwik
Biocon Biologics Limited
Attorney Name: Lauren M. Lesko
Rakoczy Molino Mazzochi Siwik
Biocon Biologics Limited
Attorney Name: Deanne M. Mazzochi
Rakoczy Molino Mazzochi Siwik
Biocon Biologics Limited
Attorney Name: Jake R. Ritthamel
Rakoczy Molino Mazzochi Siwik
Patent Owner Attorneys
4Regeneron Pharmaceuticals
Attorney Name: Adam R. Brausa
Morrison & Foerster
Regeneron Pharmaceuticals
Attorney Name: Kira A. Davis
Morrison & Foerster
Regeneron Pharmaceuticals
Attorney Name: Daralyn J. Durie
Morrison & Foerster
Related Patents
Doc No | Title | Issue date |
---|---|---|
10888601 | Use of a VEGF antagonist to treat angiogenic eye disorders | Jan 12, 2021 |